menu
    • menu

    Company profile for uBriGene Biosciences International

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    uBriGene Biosciences is a global CDMO/CRO specializing in advanced therapy medicinal products (ATMPs), founded in 2015 and headquartered in Germantown, Maryland, with operations across North America and Asia. The company provides end-to-end support from preclinical CRO services to GMP manufacturing and analytical testing for cell and gene therapies. With 100+ GMP batches, 20+ IND approvals and a strong regulatory audit record,...
    uBriGene Biosciences is a global CDMO/CRO specializing in advanced therapy medicinal products (ATMPs), founded in 2015 and headquartered in Germantown, Maryland, with operations across North America and Asia. The company provides end-to-end support from preclinical CRO services to GMP manufacturing and analytical testing for cell and gene therapies. With 100+ GMP batches, 20+ IND approvals and a strong regulatory audit record, uBriGene enables efficient translation of ATMP programs from development to commercialization.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    uBriGene Biosciences InternationalUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    20400 Century Blvd, Suite 125, Germantown, MD 20874
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ubrigene.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ubrigene, Cellinfinity Partner To Advance In Vivo CAR-T Therapy
    Ubrigene, Cellinfinity Partner To Advance In Vivo CAR-T Therapy

    30 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-30/ubrigene-and-cellinfinity-bio-announce-strategic-partnership-to-advance-in-vivo-car-t-therapies

    PHARMIWEB
    30 Mar 2026
    Share Share
    uBriGene Congratulates Grit Biotech On FDA IND Clearance
    uBriGene Congratulates Grit Biotech On FDA IND Clearance

    16 Mar 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/ubrigene-congratulates-strategic-partner-grit-biotechnologies-on-fda-ind-clearance-fo-1147334

    ACCESSWIRE
    16 Mar 2026
    Share Share
    Ubrigene Launches LVV Turbo Platform, Partners Syenex
    Ubrigene Launches LVV Turbo Platform, Partners Syenex

    16 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-16/ubrigene-launches-lvv-turbo-tm-its-next-generation-gmp-lentiviral-vector-manufacturing-platform

    PHARMIWEB
    16 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search